Comments
Loading...

CytomX Therapeutics

CTMXNASDAQ
Logo brought to you by Benzinga Data
$0.8379
-0.03-3.82%
At close: -
$0.8500
0.011.44%
After Hours: 5:05 PM EDT

CytomX Therapeutics (NASDAQ:CTMX) Stock Quotes, Forecast and News Summary

CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Aug 24
1
Sep 24
1
Nov 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.88
Close$0.84
Volume / Avg.512.75K / 1.32M
Day Range$0.83 - $0.88
52 Wk Range0.79 - 5.85
Market Cap$66.52M
P/E Ratio5.45
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest
6.17%
Days to Cover4.43

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CTMX
BNR

FAQ

Q

How do I buy CytomX Therapeutics (CTMX) stock?

A

You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CytomX Therapeutics (CTMX) competitors?

Q

What is the forecast, or price target, for CytomX Therapeutics (CTMX) stock?

A

CytomX Therapeutics has a consensus price target of $5.70.

Q

What is the current price for CytomX Therapeutics (CTMX)?

A

The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $0.85 last updated January 22, 2025 at 5:05 PM EST.

Q

Does CytomX Therapeutics (CTMX) pay a dividend?

A

There are no upcoming dividends for CytomX Therapeutics.

Q

When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?

A

CytomX Therapeutics’s Q4 earnings are confirmed for Monday, March 10, 2025.

Q

Is CytomX Therapeutics (CTMX) going to split?

A

There is no upcoming split for CytomX Therapeutics.

Q

What sector and industry does CytomX Therapeutics (CTMX) operate in?

A

CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch